Publication | Open Access

Co-administration strategy to enhance brain accumulation of vandetanib by modulating P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp1/Abcg2) mediated efflux with m-TOR inhibitors

Neuro-oncologyCo-administration StrategyMedicineM-tor InhibitorsPharmacological AgentPharmacotherapyNeuroscienceAnti-cancer AgentPharmacologyGliomaBrain AccumulationDrug Discovery